In the news | 6th Sep 2022
How to avoid common pitfalls in the tech transfer process
Even the most well-established biotechnology companies can be challenged when it comes to implementing tech transfer successfully. Tech transfer processes bridge the gap between every stage of drug development for the transfer of information about development, manufacturing and quality assurance.
Read more on this topic in our article by Ken Forman, Senior Director of Product Strategy at IDBS, published in Labiotech.eu.